Thursday, August 2, 2018

CBIO - A Printer that Classifies Cells Accurately

How I Serve



I search for emerging companies, technologies, disruptive technologies, 

innovations, start-ups and up-starts. I’ll look to match potential problems… 

e.g. “plastic pollution” to solutions… e.g. 3D Printer for recycled plastic waste…

for potential venture capitalists, angel investors, and online funders. 

I’ll also highlight a variety of topics including funding success stories, 

the environment, housing, medical, artificial intelligence, science, 

aging populations, disabled populations, social entrepreneurs, philanthropy, 

and topical news. I’m always searching for great people innovating, 

inventing, and doing, great things.




The 411: Investment Opportunity - CBIO Commercializes a Premium Live Cell Analysis Platform


Found on: https://www.cbio.io/


CBio is a life science tools company equipping researchers and clinicians with tools to help them identify predictive signatures of disease.

Our proprietary platform enables the study of living cells. Our technology identifies important differences between Normal and Abnormal living cells, preserves function, and retains usability for further study.
Our Approach:
  • Reduces the need to perform genetic analysis
  • Eliminates inefficiency commonly associated with single cell analysis
  • Identifies subcellular differences found within intact cells​
Our technology platform provides helpful solutions for CRISPR/CAS9 gene editing, study of the microbiome, stem cell research, agro-biotech, biotechnology used in cleantech, and much more. 

Existing cell analysis techniques are destructive and non-deterministic.
CBio’s cellPhoresis™ + Vision™ technology enable deterministic classification of cells.

CBio brings powerful live cell analysis to all labs with our simple and easy to use platform.












































No comments:

Post a Comment